Role of L-Ornithine L-Aspartate in cirrhosis patients with Hepatic Encephalopathy
Not Applicable
- Conditions
- Health Condition 1: K740- Hepatic fibrosis
- Registration Number
- CTRI/2019/06/019842
- Lead Sponsor
- Dr Shalimar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Patients with Overt HE (more than grade II)
Exclusion Criteria
1)Age < 18 and > 65 years
2)Acute liver failure
3)Serum creatinine > 1.5
4)Active alcohol consumption over the past 4 weeks
5)Infections other than SBP, e.g. pneumonia, frank sepsis
6)Ileus, intestinal obstruction
7)Hepatocellular carcinoma
8)Advanced cardiac or pulmonary disease
9)Underlying chronic kidney disease
10)Associated psychiatric illness
11)Pregnant or lactating women
12)Metabolic encephalopathy
13)Degenerative neurological disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method